Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis.
暂无分享,去创建一个
S. Gangemi | P. Minciullo | A. Saija | G. Di Lorenzo | M. S. Leto-Barone | S. La Piana | G. La Porta
[1] O. Kalayci,et al. Oxidative stress in the airways of children with asthma and allergic rhinitis , 2012, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[2] S. Gangemi,et al. Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene. , 2012, International journal of hygiene and environmental health.
[3] A. Allegra,et al. Relationship Between Advanced Oxidation Protein Products, Advanced Glycation End Products, and S-Nitrosylated Proteins With Biological Risk and MDR-1 Polymorphisms in Patients Affected by B-Chronic Lymphocytic Leukemia , 2012, Cancer investigation.
[4] A. Smit,et al. Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease , 2011, Arthritis research & therapy.
[5] R. Oçal,et al. Oxidative stress status and plasma trace elements in patients with asthma or allergic rhinitis. , 2011, Allergologia et immunopathologia.
[6] K. Hirata,et al. Potential roles of pentosidine in age-related and disease-related impairment of pulmonary functions in patients with asthma. , 2011, The Journal of allergy and clinical immunology.
[7] P. Black,et al. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. , 2011, Respiratory medicine.
[8] K. Carlsen,et al. Altered oxidative state in schoolchildren with asthma and allergic rhinitis , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[9] N. Martinelli,et al. Differences and Similarities between Allergic and Nonallergic Rhinitis in a Large Sample of Adult Patients with Rhinitis Symptoms , 2011, International Archives of Allergy and Immunology.
[10] Xiao-lan Li,et al. Antioxidant Status and Immune Activity of Glycyrrhizin in Allergic Rhinitis Mice , 2011, International journal of molecular sciences.
[11] F. Munschauer,et al. AGE-RAGE in Multiple Sclerosis Brain , 2011, Immunological investigations.
[12] Edyta Bieszczad-Bedrejczuk,et al. Protective effect of desloratadine against oxidative stress in human erythrocytes in vitro. , 2010, Environmental toxicology and pharmacology.
[13] Hong Wang,et al. [Changes of oxidative stress in peripheral serum of patients with allergic rhinitis]. , 2010, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.
[14] A. Fitzpatrick,et al. Obesity, asthma, and oxidative stress. , 2010, Journal of applied physiology.
[15] A. Piwowar. [Advanced oxidation protein products. Part I. Mechanism of the formation, characteristics and property]. , 2010, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
[16] F. Aksoy,et al. Advanced oxidation protein products as an oxidative stress marker in allergic rhinitis. , 2009, Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat.
[17] H. Scharnagl,et al. Plasma-Advanced Oxidation Protein Products Are Potent High-Density Lipoprotein Receptor Antagonists In Vivo , 2009, Circulation research.
[18] K. Kostikas,et al. Inflammatory and oxidative stress biomarkers in allergic rhinitis: the effect of smoking , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[19] C. Roussos,et al. Breath Markers of Oxidative Stress and Airway Inflammation in Seasonal Allergic Rhinitis , 2008, International journal of immunopathology and pharmacology.
[20] G. Viegi,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.
[21] K. Hirata,et al. Nε-(Carboxymethyl)Lysine, a Major Advanced Glycation End Product in Exhaled Breath Condensate as a Biomarker of Small Airway Involvement in Asthma , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.
[22] V. Sathiyapriya,et al. Evidence for the role of lipid peroxides on glycation of hemoglobin and plasma proteins in non-diabetic asthma patients. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[23] V. Tesar,et al. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. , 2005, Mutation research.
[24] S. Fustinoni,et al. [Biologically effective dose biomarkers]. , 2004, Giornale italiano di medicina del lavoro ed ergonomia.
[25] G. Folkerts,et al. Asthma and Oxidative Stress , 2004 .
[26] N. Martinelli,et al. Randomized placebo‐controlled trial comparing fluticasone aqueous nasal spray in mono‐therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[27] H. Tsukahara,et al. High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress. , 2003, Metabolism: clinical and experimental.
[28] J. Heinecke,et al. Production of N(epsilon)-(carboxymethyl)lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation. , 2003, Diabetes.
[29] R. Bowler,et al. Oxidative stress in allergic respiratory diseases. , 2002, The Journal of allergy and clinical immunology.
[30] W. Stahel,et al. Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[31] T. Kobayashi,et al. Exposure to ozone aggravates nasal allergy-like symptoms in guinea pigs. , 2001, Toxicology letters.
[32] J. Crowley,et al. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. , 1999, The Journal of clinical investigation.
[33] C. Caruso,et al. Allergic rhinitis to grass pollen: measurement of inflammatory mediators of mast cell and eosinophils in native nasal fluid lavage and in serum out of and during pollen season. , 1997, The Journal of allergy and clinical immunology.
[34] A. Hasan,et al. Total antioxidant status and oxidative stress and their relationship to total IgE levels and eosinophil counts in children with allergic rhinitis. , 2012, Journal of investigational allergology & clinical immunology.
[35] Y. Uyar,et al. [Oxidative stress and antioxidant factors in pathophysiology of allergic rhinitis]. , 2007, Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat.
[36] A. Długosz,et al. [Markers of oxidative balance and concentration of selected metals in pollinotics]. , 2005, Przeglad lekarski.
[37] N. Martinelli,et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in monotherapy , fluticasone plus cetirizine , fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis , 2004 .
[38] U. Markert,et al. Elevated nonspecific plasma proteins in allergic patients. , 2003, Journal of investigational allergology & clinical immunology.
[39] T. Kumoi,et al. Hydrogen peroxide generation by eosinophils in allergic rhinitis. , 1991, Auris, nasus, larynx.